Year Established :
2200
Main Competitive Advantages :
Experienced R&D Staff,Production Capacity,Contract Manufacturing (CRO,CMO)
Business Type :
All
R&D Capacity :
Own Brand
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
Western Europe,Eastern Europe,Asia,Middle East
Product Range :
"鹽酸度洛西汀 Duloxetine HCl"
"左乙拉西坦 Levetiracetam"
"奧美拉唑 Omeprazole"
"鹽酸環(huán)丙沙星 Ciprofloxacin hydrochloride"
"米拉貝隆 Mirabegron"
琥珀酸索利那新 Solifinacine
"帕博西尼 Palbociclib"
"甲磺酸樂伐替尼 Lenvatinib"
"坎格列凈半水合物 Canagliflozin Hemihydrate"
"恩格列凈 Empagliflozin"
"琥珀酸曲格列汀 Trelagliptin Succinate"
"馬西騰坦 Macitentan
""西里帕格 Selexipag"
"阿普斯特 Apremilast"
非布司他 Febsuxtat
"枸櫞酸托法替布 Tofacitinib Citrate"
"氟班色林 Flibanserin"
" 富馬酸沃諾拉贊 Vonoprazan Fumarate"